Versor Investments’s Apellis Pharmaceuticals APLS Stock Holding History

Versor Investments’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,146	Closed	-$2.06M	–	29
2026 Q1	$2.06M	Buy	+51,146	New	+$1.1M	5.04%	6

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versor Investments's APLS Position: Q2 2026 in Review

Versor Investments sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 51,146 shares — an estimated $2.06M sold.

Versor Investments first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.06M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Versor Investments reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Versor Investments sold 51,146 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.06M.
Versor Investments first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Versor Investments's Apellis Pharmaceuticals position peaked at $2.06M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Versor Investments's 13F filing for Q2 2026, filed 7 Aug 2026.